Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros













Base de datos
Intervalo de año de publicación
1.
Basic Clin Pharmacol Toxicol ; 129(5): 369-375, 2021 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-34359097

RESUMEN

PURPOSE: Relvar® (fluticasone furoate [FF]/vilanterol [VI]) is a once-daily inhaler with bronchodilator effect lasting 24 h. Our aim was to investigate the short- and long-term effects of FF/VI on exercise-induced asthma (EIA) in adolescents. METHODS: Ninety-three adolescent asthmatics aged 12-18 years were referred for evaluation of EIA. Following a positive exercise challenge test (ECT), 22/44 were allocated to a single administration of salbutamol (400 µg) and 22/44 to FF/VI (92/22 µg) in a double-blind method. Thirty-five subjects were reassessed by repeat ECT 30-60 days of FF/VI. RESULTS: Median FEV1 change post-ECT at baseline was -22.8% predicted (interquartile range [IQR] -26.1 and -18.0) for salbutamol and -21.0 (IQR -30.7 and -16.8) for FF/VI. Following bronchodilator, FEV1 improved similarly in both groups. Repeat ECT following 30-60 days of FF/VI resulted in negative ECT in 33/35 subjects; the median decrease in FEV1 of these 35 subjects was 22.6% predicted (IQR 29-18) before, and 4.6% predicted (IQR 8.7-2.5) after 30-60 days of FF/VI treatment (p < 0.0001). CONCLUSIONS: FF/VI is effective in reversing EIA after 15 min in adolescents and in protecting EIA after 30-60 days in adolescents. Larger studies are needed to assess the effect of FF/VI on EIA.


Asunto(s)
Albuterol/administración & dosificación , Androstadienos/administración & dosificación , Asma/tratamiento farmacológico , Alcoholes Bencílicos/administración & dosificación , Broncodilatadores/administración & dosificación , Clorobencenos/administración & dosificación , Administración por Inhalación , Adolescente , Albuterol/farmacología , Androstadienos/farmacología , Asma/fisiopatología , Alcoholes Bencílicos/farmacología , Broncodilatadores/farmacología , Niño , Clorobencenos/farmacología , Método Doble Ciego , Combinación de Medicamentos , Prueba de Esfuerzo , Femenino , Volumen Espiratorio Forzado/efectos de los fármacos , Humanos , Masculino , Nebulizadores y Vaporizadores , Estudios Prospectivos , Factores de Tiempo , Resultado del Tratamiento
2.
J Gastrointest Surg ; 21(6): 1062-1066, 2017 06.
Artículo en Inglés | MEDLINE | ID: mdl-28424984

RESUMEN

BACKGROUND AND STUDY AIMS: Accidental swallowing of hijab (or turban) pin was reported mainly among adolescent girls. Current guidelines indicate emergent intervention endoscopy in case a long sharp object is found in the gastrointestinal tract. The aims of the current study are to present the results of an observational approach and to assess the need for intervention. PATIENTS AND METHODS: A retrospective cohort study was conducted including all 5-18-year-old patients who presented with hijab-pin ingestion between 2003 and 2014. The need for intervention was assessed using both univariable and multivariable statistical analyses. RESULTS: Two hundred three cases of hijab-pin ingestion were documented. In the majority of cases, the pin was observed in the stomach (137/203, 67.4%) upon arrival. Most pins that were located at the upper gastrointestinal tract (proximal to the ligament of Treitz) ejected spontaneously (120/169, 71%, Pv = 0.005). The absence of pin progression in an X-ray performed 12 h following presentation was significantly more frequent in the intervention group (46/51, 90%, Pv = 0.001). CONCLUSIONS: In most cases, the outcome is spontaneous ejection from the digestive tract. However, if needle location remains unchanged on two consecutive X-rays, an endoscopic intervention is recommended.


Asunto(s)
Duodeno , Endoscopía Gastrointestinal , Cuerpos Extraños/terapia , Estómago , Espera Vigilante , Adolescente , Niño , Femenino , Cuerpos Extraños/diagnóstico por imagen , Humanos , Remisión Espontánea , Estudios Retrospectivos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA